Once again, a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
ARIA stock had traded over $20 a share in September, but ARIA stock plunged in October after the U.S. Food and Drug Administration halted a trial of its anti-cancer treatment, Iclusig, after some patients developed blood clots. The buyers …
Shire’s stock price had fallen 45 percent in the 15 months before ... Early last …
Bump stock manufacturers under fire The Justice Department said ... (Madison …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses …
One stock that might be an intriguing choice for investors right now is Ariad Pharmaceuticals Inc. ( ARIA). This is because this security in the Medical-Drugs is seeing solid earnings estimate revision activity, and is in great company from a …
All said, on Friday, the day the drug was approved, instead of rejoicing, Wall street cremated Ariad's stock. Why? They mention the side effects and a warning box that analysts didn't know about. These reasons are totally irrelevant. The …
Major biotech stocks like Amgen AMGN and Gilead GILD reported fourth quarter results -- while both topped estimates, revenue outlook fell short of expectations. Recap of the Week’s Most Important Stories Amgen Delivers Strong Quarter …
Bump stock manufacturers under fire The Justice Department said ... (Madison Miller/Las Vegas Review-Journal Correspondent) Suspected Aria counterfeiter …